Immunopathology of secondary‐progressive multiple sclerosis
暂无分享,去创建一个
E. Cho | M. Barnett | B. Morgan | J. Prineas | E. Kwon | L. Sharer | E. Oleszak | Brad Hoffman | Brad E. Hoffman
[1] J. Parisi,et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.
[2] B. Scheithauer,et al. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. , 1999, Brain : a journal of neurology.
[3] V. Stevenson,et al. Magnetic resonance imaging in the monitoring of disease progression in multiple sclerosis , 1999, Multiple sclerosis.
[4] S. Hauser,et al. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: A case for antigen‐specific antibody mediation , 1999, Annals of neurology.
[5] Bruce D. Trapp,et al. Axonal pathology in myelin disorders , 1999, Journal of neurocytology.
[6] P. Sminia,et al. Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures. , 1999, Journal of neuropathology and experimental neurology.
[7] R. Rudick,et al. Neurodegeneration in Multiple Sclerosis: Relationship to Neurological Disability , 1999 .
[8] P M Matthews,et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. , 1998, Brain : a journal of neurology.
[9] M. Filippi,et al. Newer magnetic resonance techniques and disease activity in multiple sclerosis: new concepts and new concerns , 1998, Multiple sclerosis.
[10] H. Lassmann,et al. Multiple sclerosis: In situ evidence for antibody‐ and complement‐mediated demyelination , 1998, Annals of neurology.
[11] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[12] M. Esiri,et al. The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion. , 1997, Brain : a journal of neurology.
[13] R. Hohlfeld,et al. Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives. , 1997, Brain : a journal of neurology.
[14] V. Perry,et al. Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.
[15] W. Russell. Molecular biology of multiple sclerosis , 1997 .
[16] J. Newcombe,et al. The Expression of Tissue‐type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis: Comparison of Stages in Lesion Evolution , 1996, Journal of neuropathology and experimental neurology.
[17] A J Thompson,et al. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. , 1996, Brain : a journal of neurology.
[18] L. Laan,et al. Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-α and nitric oxide , 1996, Journal of Neuroimmunology.
[19] B. Trapp,et al. Distribution of immunoglobulin superfamily members ICAM-1, -2, -3, and the beta 2 integrin LFA-1 in multiple sclerosis lesions. , 1996, Journal of neuropathology and experimental neurology.
[20] M. Cuzner,et al. Biochemistry of Demyelination , 1996, Brain pathology.
[21] P M Matthews,et al. Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. , 1996, Brain : a journal of neurology.
[22] J Newcombe,et al. Microglia‐derived macrophages in early multiple sclerosis plaques , 1996, Neuropathology and applied neurobiology.
[23] R. Locksley,et al. The Instructive Role of Innate Immunity in the Acquired Immune Response , 1996, Science.
[24] R. Sobel,et al. Matrix Metalloproteinases in the Normal Human Central Nervous System, Microglial Nodules, and Multiple Sclerosis Lesions , 1996, Journal of neuropathology and experimental neurology.
[25] P. Mcgeer,et al. Neurofibrillary tangles of Guam parkinson-dementia are associated with reactive microglia and complement proteins , 1996, Brain Research.
[26] Hans Lassmann,et al. Monocyte/macrophage differentiation in early multiple sclerosis lesions , 1995, Annals of neurology.
[27] R. Mrak,et al. Interleukin‐1 Expression in Different Plaque Types in Alzheimer's Disease: Significance in Plaque Evalution , 1995, Journal of neuropathology and experimental neurology.
[28] P. Mattsson,et al. Evidence for activation of the terminal pathway of complement and upregulation of sulfated glycoprotein (SGP)-2 in the hypoglossal nucleus following peripheral nerve injury. , 1995, Molecular and chemical neuropathology.
[29] Jack Antel,et al. Phenotypic Differences between Human Monocytes/Macrophages and Microglial Cells Studied In Situ and In Vitro , 1994, Journal of neuropathology and experimental neurology.
[30] A J Thompson,et al. A comparison of the pathology of primary and secondary progressive multiple sclerosis. , 1994, Brain : a journal of neurology.
[31] K. Williams,et al. Activation of adult human derived microglia by myelin phagocytosis in vitro , 1994, Journal of neuroscience research.
[32] P. Matthews,et al. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis , 1994, Annals of neurology.
[33] J. Antel,et al. Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG , 1994, Journal of the Neurological Sciences.
[34] A. Olivier,et al. Fc Receptors for IgG on Cultured Human Microglia Mediate Cytotoxicity and Phagocytosis of Antibody-coated Targets , 1994, Journal of neuropathology and experimental neurology.
[35] M. Cuzner,et al. Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. , 1993, Cytokine.
[36] G. Opdenakker,et al. Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein , 1993, Journal of neuroscience research.
[37] H. Rabb,et al. Cytoplasmic tails of human complement receptor type 3 (CR3, CD11b/ CD18) regulate ligand avidity and the internalization of occupied receptors. , 1993, Journal of immunology.
[38] W. Tourtellotte,et al. On classification of post-mortem multiple sclerosis plaques for neuroscientists , 1993, Journal of Neuroimmunology.
[39] J. Newcombe,et al. Characterization and distribution of phagocytic macrophages in multiple sclerosis plaques , 1993, Neuropathology and applied neurobiology.
[40] C. Raine,et al. Multiple Sclerosis: Remyelination in Acute Lesions , 1993, Journal of neuropathology and experimental neurology.
[41] E. Cho,et al. Multiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions , 1993 .
[42] D. Walker,et al. Microglia in degenerative neurological disease , 1993, Glia.
[43] E. Cho,et al. Multiple sclerosis: remyelination of nascent lesions. , 1993, Annals of neurology.
[44] P. Mcgeer,et al. Complement activation by beta-amyloid in Alzheimer disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[45] B E Kendall,et al. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. , 1991, Brain : a journal of neurology.
[46] W. Mcdonald,et al. The longstanding MS lesion. A quantitative MRI and electron microscopic study. , 1991, Brain : a journal of neurology.
[47] H. Link,et al. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls , 1991, Journal of Neuroimmunology.
[48] Sunhee C. Lee,et al. Multiple Sclerosis: A Role for Astroglia in Active Demyelination Suggested by Class II MHC Expression and Ultrastructural Study , 1990, Journal of neuropathology and experimental neurology.
[49] J. Prineas,et al. Sera from MS patients and normal controls opsonize myelin , 1990, Neuroscience Letters.
[50] J. Benjamins,et al. Opsonization of normal myelin by anti-myelin antibodies and normal serum , 1989, Journal of Neuroimmunology.
[51] L. Scheinberg,et al. On the immunopathology of plaque development and repair in multiple sclerosis , 1988, Journal of Neuroimmunology.
[52] H. Lassmann,et al. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. , 1988, The American journal of pathology.
[53] E. G. Gray,et al. Alzheimer’s disease: coated vesicles, coated pits and the amyloid-related cell , 1988, Proceedings of the Royal Society of London. Series B. Biological Sciences.
[54] C. Brosnan,et al. Complement potentiates the degradation of myelin proteins by plasmin: Implications for a mechanism of inflammatory demyelination , 1986, Brain Research.
[55] M. Shin,et al. Isolation of Membrane Attack Complex of Complement from Myelin Membranes Treated with Serum Complement , 1984, Journal of neurochemistry.
[56] L. Epstein,et al. Attachment of myelin to coated pits on macrophages in experimental allergic encephalomyelitis , 1983, Journal of the Neurological Sciences.
[57] Dr. med. Hans Lassmann. Comparative Neuropathology of Chronic Experimental Allergic Encephalomyelitis and Multiple Sclerosis , 1983, Schriftenreihe Neurologie / Neurology Series.
[58] M. Shin,et al. Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[59] J. Mussini,et al. [Immunology of multiple sclerosis]. , 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.
[60] L. Scheinberg,et al. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion. , 1981, Laboratory investigation; a journal of technical methods and pathology.
[61] H. Fleury,et al. FURTHER ULTRASTRUCTURAL OBSERVATIONS OF VIRUS MORPHOGENESIS AND MYELIN PATHOLOGY IN JHM VIRUS ENCEPHALOMYELITIS , 1980, Neuropathology and applied neurobiology.
[62] H. Nyland,et al. Fc receptors of microglial lipophages in multiple sclerosis. , 1980, The New England journal of medicine.
[63] M. Cuzner,et al. Proteolytic enzyme activity of blood leukocytes and cerebrospinal fluid in multiple sclerosis , 1978, Annals of neurology.
[64] J. Prineas,et al. The fine structure of chronically active multiple sclerosis plaques , 1978, Neurology.
[65] J. Aarli,et al. Binding of normal human IgG to myelin sheaths, glia and neurons. , 1975, Immunology.